A detailed history of Sigma Planning Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 41,676 shares of MRK stock, worth $5.32 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
41,676
Previous 20,264 105.67%
Holding current value
$5.32 Million
Previous $2.21 Million 148.94%
% of portfolio
0.18%
Previous 0.17%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$113.24 - $131.95 $2.42 Million - $2.83 Million
21,412 Added 105.67%
41,676 $5.5 Million
Q4 2023

Feb 01, 2024

SELL
$100.18 - $109.02 $2.6 Million - $2.83 Million
-25,974 Reduced 56.17%
20,264 $2.21 Million
Q3 2023

Nov 06, 2023

SELL
$102.95 - $114.33 $487,880 - $541,809
-4,739 Reduced 9.3%
46,238 $4.76 Million
Q2 2023

Aug 01, 2023

SELL
$108.61 - $118.38 $2.56 Million - $2.8 Million
-23,614 Reduced 31.66%
50,977 $5.88 Million
Q1 2023

May 05, 2023

SELL
$102.94 - $114.86 $767,623 - $856,511
-7,457 Reduced 9.09%
74,591 $7.94 Million
Q4 2022

Jan 24, 2023

SELL
$87.44 - $112.11 $772,532 - $990,491
-8,835 Reduced 9.72%
82,048 $0
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $299,743 - $336,728
3,546 Added 4.06%
90,883 $7.83 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $600,961 - $681,218
7,198 Added 8.98%
87,337 $7.96 Million
Q1 2022

Apr 20, 2022

BUY
$73.51 - $82.4 $67,114 - $75,231
913 Added 1.15%
80,139 $6.58 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $174,700 - $218,835
2,417 Added 3.15%
79,226 $6.07 Million
Q3 2021

Oct 28, 2021

BUY
$71.68 - $78.83 $40,212 - $44,223
561 Added 0.74%
76,809 $5.77 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $192,157 - $212,545
2,733 Added 3.72%
76,248 $5.93 Million
Q1 2021

May 06, 2021

BUY
$68.86 - $81.11 $672,211 - $791,795
9,762 Added 15.31%
73,515 $5.67 Million
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $219,257 - $243,330
3,055 Added 5.03%
63,753 $5.22 Million
Q3 2020

Nov 03, 2020

SELL
$73.18 - $82.95 $9,952 - $11,281
-136 Reduced 0.22%
60,698 $5.04 Million
Q2 2020

Jul 31, 2020

BUY
$70.42 - $80.13 $541,248 - $615,879
7,686 Added 14.46%
60,834 $4.7 Million
Q1 2020

May 01, 2020

BUY
$63.36 - $87.82 $334,984 - $464,304
5,287 Added 11.05%
53,148 $4.09 Million
Q4 2019

Feb 03, 2020

BUY
$77.58 - $87.54 $58,185 - $65,655
750 Added 1.59%
47,861 $4.35 Million
Q3 2019

Nov 01, 2019

BUY
$76.08 - $82.93 $46,180 - $50,338
607 Added 1.31%
47,111 $3.97 Million
Q2 2019

Aug 01, 2019

BUY
$69.84 - $81.59 $236,827 - $276,671
3,391 Added 7.87%
46,504 $3.9 Million
Q1 2019

May 01, 2019

SELL
$69.58 - $79.36 $25,883 - $29,521
-372 Reduced 0.86%
43,113 $3.59 Million
Q4 2018

Jan 31, 2019

SELL
$65.24 - $75.71 $30,010 - $34,826
-460 Reduced 1.05%
43,485 $3.32 Million
Q3 2018

Nov 07, 2018

BUY
$57.69 - $67.84 $47,248 - $55,560
819 Added 1.9%
43,945 $3.12 Million
Q2 2018

Aug 02, 2018

SELL
$50.83 - $59.72 $12,250 - $14,392
-241 Reduced 0.56%
43,126 $2.62 Million
Q1 2018

May 11, 2018

SELL
$50.96 - $59.23 $325,889 - $378,775
-6,395 Reduced 12.85%
43,367 $2.36 Million
Q4 2017

Feb 07, 2018

BUY
$51.62 - $61.64 $59,156 - $70,639
1,146 Added 2.36%
49,762 $2.8 Million
Q3 2017

Nov 06, 2017

BUY
$58.67 - $63.13 $2.85 Million - $3.07 Million
48,616
48,616 $3.11 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.